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SUMMARY
Deaths from malignant melanoma in each part ofthe British Isles between 1969
and 1984 have been examined. There has been a substantial increase ofdeaths
among women in each part, and an increase ofsimilar magnitude among men in
all areas except Northern Ireland. It is suggested that this difference requires
furtherstudy. The increasing number ofdeaths from this disease indicates a need
forgreater public andprofessional awareness ofthis potentially preventable and
curable condition.
INTRODUCTION
Deaths from malignant melanoma in the United Kingdom have increased
substantially in the last 20 years.1
A recent report on the incidence of malignant melanoma in Northern Ireland
drew attention to an excess of cases among females, and in this review of
specimens submitted for pathological examination a female-to-male ratio of
almost three -to - one was found.2 There is a widespread international variation in
the female -to -male ratio. British and American studies have reported a female
excess,3,4 but in Belgium, Holland and Scandinavia, in the period 1955-1974,
there was a considerable male excess.3 I have examined deaths from malignant
melanoma over a 16-year period in order to see whether mortality has varied
over time in Northern Ireland, and to compare this with the experience in the
remaining parts of the British Isles.
METHODS
Deaths from malignant melanoma (ICD-9 Code 172) were extracted from the
annual reports of the Registrar -General for Northern Ireland for the years 1969
to 1984. It was not possible to determine the histological type from this source.
Corresponding figures for England and Wales, Scotland, and the Republic of
Ireland were extracted from OPCS Mortality statistics, reports of the Registrar-
General for Scotland, and Reports on vital statistics from the Central Statistical
Office, Dublin. Data for the Republic of Ireland were only analysed for the period
1969 to 1982. The standardised mortality ratios (SMR) were calculated by
comparing the annual average number of deaths throughout the period with the
age-specific death rates for England and Wales during 1976, the mid-point of
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the period, related to the population estimate for Northern Ireland in that year.
The variation of deaths over time were examined by plotting a scattergram and by
regression analysis, and the significance ofthe regression equation was examined
by analysis of variance.
RESULTS
One hundred and twenty men and 176 women died from malignant melanoma
in Northern Ireland during the period studied. Deaths among males were slightly
less common and among females were significantly so in Northern Ireland as
compared with England and Wales. The SMR is 0.90 ± 0.16 for males and
0.84 ± 0.12 for females (95% confidence intervals). (British Isles = 1.00).
There was no significant trend of deaths among males (F = 0.083, 14 df). There
was a significant increase in female deaths throughout the period (F =8.09,
14 df, p < 0.05). The regression coefficient is 0.605. The trend represented an
increase of 1 73% or from approximately 6 to 16 deaths per year among females
while male deaths remained constant at about eight per year.
When analysed by ten-year age groups, there was no significant difference
between the age at death of males and females (Chi squared = 7.43, 14 df).
There was an increase in deaths from melanoma among females in each part of
the British Isles, but the increase is greatest in Northern Ireland. This is the only
part of the British Isles in which there was not a significant increase in male
deaths, and is the only one in which there was a significant difference between the
trend of deaths among males and females (t = 2.25, p < 0.05) (Table).
TABLE
Percentage increase in deaths from malignant melanoma in the British Isles
1969-1984
Male Female Ratio of
percentage percentage female- to-male
increase increase deaths
1969 - 84 1969 - 84
Northern Ireland 8% NS 173% p< 0.05 1.47
(n = 120) (n = 176)
England and Wales 96% p < 0.001 70% p < 0.001 1.26
(n = 5203) (n = 6580)
Scotland 56% p < 0.05 49% p < 0.01 1.53
(n =458) (n =703)
Republic of Ireland* 100% p < 0.05 101 % p < 0.05 1.41
(n = 188) (n = 266)
Increases have been calculated from the equations of the trends.
Sources: Annual reports of the Registrar-General for Northern Ireland, OPCS Mortality statistics,
Reports of the Registrar-General for Scotland, and Reports on vital statistics from the Central
Statistical Office, Dublin.
* 1969- 1982 only.
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DISCUSSION
There has been a rapid rise in the incidence of malignant melanoma among
people of Northern European descent in many parts ofthe world.5 Total mortality
in the British Isles has almost doubled since 1969 and elsewhere: a report from
Sweden documented an increase of 7 % in both sexes in the period 1959-68.5
The relationship between lentigo malignant melanoma and ultra -violet light is
well recognised, although the association with superficial spreading melanoma
and nodular melanoma is less well established.
People of Celtic descent may have a genetic predisposition and studies from
Australia6 and the United States7 have found that the incidence is significantly
higher among those with names suggesting Irish or Scottish ancestry.
In Northern Ireland there is a marked difference in deaths from melanoma in
males and females. As it is not necessarily a fatal condition, this may reflect either
a difference in incidence or in prognosis. In Gordon and Lowry's comprehensive
study of the incidence of melanoma in Northern Ireland in 1974-78 there were
170 females and 61 males.2 During the same period there were 28 male and 49
female deaths. This suggests a higher case fatality rate among men, which is
consistent with the observation that they have a higher proportion of thicker, and
therefore more advanced, lesions among biopsies.2 A higher male case fatality
hasalso beenfound in England and Wales.3 Taken with the evidenceof increasing
mortality, this suggests that the rise in incidencein femalesinthe same population
may be very much greater. Walsh and Bharucha8 in their study of samples
submitted for histological examination in 1930, 1955 and 1980, found that the
female-to -male ratio in their sample had increased from 1.5:1 in 1955 to 2.3 :1
in 1980. It would seem that melanomas are much more common in women but
are also likely to be diagnosed earlier.
The reason for the absence of an increase in male deaths in Northern Ireland is
uncertain, especially since it is at variance with findings from other parts of the
British Isles. It is possible that it may be related to differences in behaviour of male
and female holidaymakers from Northern Ireland. A case control study would be
useful to examine this hypothesis further. A further possibility is incorrect
certification of the cause of death. Although considerable inaccuracies in death
certification have been found,9 a large study of 9,501 deaths 10 comparing
clinicians' diagnosesand post-mortem findings established substantial agreement
in deaths from many types of neoplasms. The disagreements were more likely to
occur in conditions which tend to present with secondary spread, and in which
the primary site may be difficult to locate, or among neoplasms which are
recognised to present occasionally with non-metastatic complications, such as
bronchial neoplasms. It would seem reasonable to suggest that neoplasms of skin
would be less likely to be misdiagnosed in comparison with neoplasms of other
sites. It is difficult to see how misdiagnosis could consistently and systematically
affect one sex to a greater degree than the other over a 16-year period.
Unfortunately, cancer registration in Northern Ireland is incomplete and, when
examined in 1983, it was found to have included less than 50% of skin
malignancies identified from laboratory records. Coverage of the Province is
variable with under-representation of the western part of the Province.1' It is
hoped that improvements in the register will make it possible to investigate future
trends.
The observation of lower overall mortality in Northern Ireland as compared with
other parts of the United Kingdom is consistent with studies of incidence of
© The Ulster Medical Society, 1988.
64Malignant melanoma in women 65
melanoma based on pathological specimens which have reported an annual
incidence in Northern Ireland of 3.12/100,000 population2 compared with
5.1/100,000 in Scotland.4 The reasons for this are uncertain and may be related
to differences in foreign travel. The expenditure on holidays by Northern Ireland
residents is one of the lowest in the United Kingdom and is substantially lower
than expenditure by residents of Scotland.'2
Increasing mortality from melanoma has been actively confronted in several
countries. Intensive public health campaigns in Queensland 13 and in Scotland 14
have increased both public awarenessand thenumberof casesthat arediagnosed
early. Where they are still relatively uncommon they may often be missed by
doctors and only recognised at a late stage.15 Walsh and Bharucha8 have shown
that, although there was some improvement between 1955 and 1980 among the
samples in their study, by 1980 50% of lesions involved the reticular dermis or
subcutaneous fat, and there had been no increase in the percentage which were
confined to the epidermal layer.
Leaflets giving advice on exposure to the sun are now being distributed with
inclusive tour tickets through travel agents in Northern Ireland. The leaflets
contain adviceon the useofsunscreensand recognitionofmalignant melanomas.
This should increase knowledge of the risk from melanoma, and promote earlier
detection. There is a need for greater public and professional awareness of this
potentially preventable and curable condition.
REFERENCES
1. Acheson ED. From the Chief Medical Officer: Mortality of cutaneous malignant melanoma.
Health Trends 1986; 18: 73.
2. Gordon LG, Lowry WSB. The incidence and pathogenesis of invasive cutaneous malignant
melanoma in Northern Ireland. BrJ Cancer 1986; 53: 75-80.
3. Lee JAH, Storer BE. Excess of malignant melanomas in women in the British Isles. Lancet
1980; 2: 1337-9.
4. Hicks N, Zack M, Caldwell GC, McKinley TW. Life-style factors among patients with melanoma.
South Med J 1985; 78: 903 -8.
5. Malec E, Eklund G. The changing incidence of malignant melanoma of the skin in Sweden,
1959-1968. Scand J Plast Reconstr Surg 1978; 12: 19-27.
6. Lane Brown MM, Sharpe CAB, McMillan CS, McGovern VJ. Genetic predisposition to malignant
melanoma and other skin cancers in Australia. Med J Aust 1971; 1: 852-3.
7. Lane Brown MM, Melia DF. Celticity and cutaneous malignant melanoma in Massachusetts.
In: McGovern VJ, Russell P, eds. Mechanisms in pigmentation: proceedings of the 8th
International Pigment Cell Conference, Sydney, 1972. Basel: Karger, 1973. (Pigment cell, v. 1).
8. Walsh MY, Bharucha H. Malignant melanoma over a fifty-year period: a histological evaluation.
(Jlster Med J 1986; 55: 118.23.
9. Royal College of Physicians of London: Medical Services Study Group. Death certificates and
epidemiological research. Br Med J 1978; 2: 1063-5.
10. Heasman MA, Lipworth L. Accuracy of certification of cause of death. London: HMSO,
1966. (General Register Office. Studies of medical and population subjects, no. 20).
11. Gavin AT. Cancer registration in Northern Ireland. London: University of London, 1985.
MSc thesis.
12. Department of Employment. Family expenditure survey 1985. London: HMSO, 1986.
13. Little JH, Holt J, Davis N. Changing epidemiology of malignant melanoma in Queensland.
Med JAust 1980; 1: 66-9.
14. DohertyVR, Mackie RM. Reasons forpoor prognosis in British patients with cutaneous malignant
melanoma. Br Med J 1986; 292: 987-9.
15. Monk BE, Neill SM, DuVivierAWP. Missed malignant melanomas. BrMedJl1986; 292: 1000-1.
© The Ulster Medical Society, 1988.